Immunovant has announced topline results from a proof-of-concept study evaluating treatment imeroprubart (IMVT-1402) in people with cutaneous lupus erythematosus (CLE).
This post was originally published on this site
GREATER OHIO CHAPTER
Toll Free: 1 (888) NO-LUPUS
Phone: (440) 717-0183
Help Us Solve The Cruel MysteryTM